Next-generation sequencing in precision oncology: challenges and opportunities

Area of Science:

• Genomics
• Oncology
• Molecular Diagnostics

Background:

• High throughput gene sequencing, particularly next-generation sequencing (NGS), is increasingly vital in patient care, especially for precision oncology.
• NGS provides physicians with powerful tools for disease diagnosis and management.
• The integration of genomics into clinical practice is rapidly advancing.

Discussion:

• Developing NGS-based diagnostic assays presents challenges, including assessing tumor heterogeneity, differentiating driver and passenger mutations, and establishing detection limits.
• Bioinformatics analyses for clinical laboratories require robust methods to handle complex genomic data.
• Accurate interpretation of genomic data is crucial for clinical decision-making.

Key Insights:

• NGS has the potential to impact all aspects of cancer treatment, from early detection via screening to assessing treatment efficacy.
• Detecting circulating tumor DNA through noninvasive blood draws (liquid biopsies) is a key application of NGS.
• NGS enables personalized treatment strategies in oncology.

Outlook:

• As NGS utilization in precision oncology matures, it can be applied throughout a patient's cancer journey.
• NGS-based tests can facilitate continuous monitoring of cancer.
• This technology may shift cancer management paradigms, treating it more like a chronic disease.